Teva Pharmaceutical Industries Ltd (TEVA)

TEVA (NYSE:Drugs) EQUITY
$64.41
pos +0.00
+0.00%
Today's Range: 62.80 - 64.52 | TEVA Avg Daily Volume: 5,570,500
Last Update: 04/24/15 - 4:04 PM EDT
Volume: 0
YTD Performance: 12.00%
Open: $0.00
Previous Close: $63.25
52 Week Range: $47.36 - $68.75
Oustanding Shares: 851,871,888
Market Cap: 53,880,896,916
6-Month Chart
TheStreet Ratings Grade for TEVA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 12 11 11
Moderate Buy 1 1 1 1
Hold 7 9 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.71 1.86 1.95 1.95
Latest Dividend: 0.29
Latest Dividend Yield: 1.82%
Dividend Ex-Date: 02/17/15
Price Earnings Ratio: 42.45
Price Earnings Comparisons:
TEVA Sector Avg. S&P 500
42.45 17.80 28.22
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.57% 29.23% 42.03%
GROWTH 12 Mo 3 Yr CAGR
Revenue -0.20 0.11 0.03
Net Income 142.80 0.10 0.03
EPS 138.50 0.15 0.05
Earnings for TEVA:
EBITDA 6.00B
Revenue 20.27B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $1.26 $1.28 $5.16 $5.10
Number of Analysts 12 11 18 17
High Estimate $1.34 $1.32 $5.30 $5.38
Low Estimate $1.20 $1.23 $5.03 $4.46
Prior Year $1.22 $1.23 $5.07 $5.16
Growth Rate (Year over Year) 3.01% 3.77% 1.69% -1.07%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Bret Jensen

 | Apr 24, 2015 | 11:00 AM EDT

Watch for small biotechs partnering with bigger firms.

By

Antonia Oprita

 | Apr 22, 2015 | 5:30 AM EDT

And four other things you need to know now.

By

David Peltier

 | Apr 21, 2015 | 4:49 PM EDT

U.S. stocks were mixed on Tuesday.

By

Jim Cramer

 | Apr 21, 2015 | 3:44 PM EDT

Biotech companies are saying, "I do."

By

David Katz

 | Apr 21, 2015 | 1:05 PM EDT

Teva bid highlights M&A action in health care sector.

By

David Katz

 | Apr 21, 2015 | 12:53 PM EDT

Teva bid highlights M&A action in health care sector.

By

Jim Cramer

 | Apr 9, 2015 | 1:58 PM EDT

These companies are the hottest thing going.

By

Bret Jensen

 | Apr 9, 2015 | 11:00 AM EDT

Recent activity has heated up and is creating shareholder value.

By

Suz Smith

 | Apr 8, 2015 | 5:00 PM EDT

In breakout mode, the stock is looking to continue its upward path.

By

John Reese

 | Apr 6, 2015 | 8:00 AM EDT

With so much M&A action, now's the time to invest in the sector.

What I find even stranger is the inability to put the Apple Watch on even when you are in ...
A Kinder Morgan (KMI) director unloaded 1 MM shares for $43.696 MM last week (on Apr. 20 +...
CMG's CEO sold 12,000 shares at $690 - $695 for a total on $8.021 MM on April 21, 2015. CM...
Technical analysis is, in large measure, about finding repetitive price patterns and somet...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.